AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer
Innate Pharma SA’s (NASDAQ:IPHA) futility interim analysis of the INTERLINK-1 Phase 3 study sponsored by AstraZeneca Plc (NASDAQ:AZN) did not meet a…
Akari Therapeutics To Reallocate Cash And Resources To Phase 3 Trial On Nomacopan In HSCT-TMA And To Pre-Clinical Program Of PAS-Nomacopan In GA; Will Discontinue Clinical Program Evaluating Nomacopan In Bullous Pemphigoid, Says Is Not Reducing Headcou…
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that it is prioritizing two pipeline programs. Cash and
Armata Pharmaceuticals Announces Clearance Of IND For Prosthetic Joint Infections
Second indication for AP-SA02 which targets Staphylococcus aureus including MRSA
Potential to significantly improve PJI patient outcomes
Expands Armata's pursuit of phage therapy as a solution for
Aileron Therapeutics Outlines Strategy To Strengthen Phase 1b Clinical Trial Of ALRN-6924 In Patients With p53-Mutated Breast Cancer
Enhancements to protocol, informed by recent ALRN-6924 data, are designed to improve the opportunity to demonstrate protection against chemotherapy-induced severe neutropenia, alopecia (hair loss) and potentially other toxicities in patients with p53-mutated breast cancer
Fennec Pharma to Receive Investment from Petrichor Healthcare Management, $5M of Convertible Debt to be Purchased Upon Closing
An additional $20 million to be funded upon the potential U.S. Food and Drug Administration (FDA) approval of PEDMARKTM by September 30, 2022 and satisfaction of other closing conditions. Fennec upon
Eledon Secures FDA Clearance For Kidney Transplant Rejection Study
The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ: ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant.
Beam Therapeutics Announces FDA Clinical Hold On BEAM-201 IND Application
Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that on Friday, July 29, 2022, the company was informed via e-mail communication
FDA Removes Clinical Hold On Celyad’s Colorectal Cancer Trial
The FDA has lifted the clinical hold on Celyad Oncology SA’s (NASDAQ:CYAD) CYAD-101-002 (KEYNOTE-B79) Phase 1b trial after the company made changes…
Gordon Ramsay’s TikTok Video Featuring Hapless Lamb Earns Online Backlash: ‘That Crosses The Line’
A TikTok video posted by celebrity British chef Gordon Ramsay’s official account is earning some backlash online.
What Happened: Gordon can be seen creeping up on some lambs in a pen in the video saying “I’m going to eat you” to the lambs while crossing into the enclosure.